JCI Insight. 2017 Mar 9;2(5):e91327. doi: 10.1172/jci.insight.91327.
Pulmonary hypertension (PH) is a multifaceted vascular disease where development and severity are determined by both genetic and environmental factors. Over the past decade, there has been an acceleration of the discovery of molecular effectors that mediate PH pathogenesis, including large numbers of microRNA molecules that are expressed in pulmonary vascular cell types and exert system-wide regulatory functions in all aspects of vascular health and disease. Due to the inherent pleiotropy, overlap, and redundancy of these molecules, it has been challenging to define their integrated effects on overall disease manifestation. In this review, we summarize our current understanding of the roles of microRNAs in PH with an emphasis on potential methods to discern the hierarchical motifs governing their multifunctional and interconnected activities. Deciphering this higher order of regulatory structure will be crucial for overcoming the challenges of developing these molecules as biomarkers or therapeutic targets, in isolation or combination.
肺动脉高压(PH)是一种多方面的血管疾病,其发生和严重程度由遗传和环境因素共同决定。在过去的十年中,人们加速了对介导 PH 发病机制的分子效应物的发现,其中包括大量在肺血管细胞类型中表达的 microRNA 分子,它们在血管健康和疾病的各个方面发挥系统范围的调节功能。由于这些分子具有内在的多效性、重叠性和冗余性,因此很难确定它们对整体疾病表现的综合影响。在这篇综述中,我们总结了我们目前对 microRNAs 在 PH 中的作用的理解,重点介绍了潜在的方法来辨别控制其多功能和相互关联活动的层次结构模式。解析这种更高层次的调控结构对于克服将这些分子作为生物标志物或治疗靶点进行单独或联合开发的挑战至关重要。